|Investment date||September 2013|
|Exit date||December 2016|
|Exit type||Trade sale|
|Total investment||£7.8 million|
|Realised proceeds||£22.8 million|
Cyprotex was a contract research organisation specialising in in-vitro and in-silico ADME-tox testing. It was a leading outsource provider of such services to the pharmaceutical industry. It also provided in-vitro toxicity testing to the cosmetics and agrochemical industries; and had laboratories in both the UK and the US.